BlueSphere Bio, Inc. — Form D
BlueSphere Bio, Inc. of PITTSBURGH, PA, a company, filed a Form D exempt-offering notice with the SEC on 2018-10-01. The offering totals $15.0M, of which $10.0M was reported sold. Industry: Other.
Offering
- Filed: 2018-10-01
- Form: D
- Accession: 0001754734-18-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $15.0M
- Amount sold: $10.0M
- Remaining: $5.0M
- Investors: 1
- Date of first sale: 2018-09-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-322467
Issuer
- Name: BlueSphere Bio, Inc.
- CIK: 0001754734
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 350 TECHNOLOGY DRIVE, SUITE 510, PITTSBURGH, PA, 15219
- Phone: 412-863-7307
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Tal Heppenstall | Director | Seattle, WA |
| Mark Shlomchik | Executive Officer | PITTSBURGH, PA |
| Warren Shlomchik | Executive Officer | Pittsburgh, PA |
| Jeanne Cunicelli | Director | Pittsburgh, PA |
| Robert Lin | Director | Hatfield, PA |
| Mark Shlomchik | Director | PITTSBURGH, PA |
| Alan Korman | Director | PITTSBURGH, PA |
| David Apelian | Director | PITTSBURGH, PA |
| David Apelian | Executive Officer | PITTSBURGH, PA |
Other filings by this issuer (1)
More